Advanced search
Publication Cover
Infectious Diseases Volume 50, 2018 - Issue 5
Submit an article Journal homepage
288
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy

Leonardo CalzaS. Orsola-Malpighi Hospital, Clinic of Infectious Diseases, ‘Alma Mater Studiorum’ University of Bologna, Bologna, Italy; Correspondence[email protected]
,
Matteo CafaggiS. Orsola-Malpighi Hospital, Clinic of Infectious Diseases, ‘Alma Mater Studiorum’ University of Bologna, Bologna, Italy;
,
Vincenzo ColangeliS. Orsola-Malpighi Hospital, Clinic of Infectious Diseases, ‘Alma Mater Studiorum’ University of Bologna, Bologna, Italy;
,
Marco BorderiS. Orsola-Malpighi Hospital, Clinic of Infectious Diseases, ‘Alma Mater Studiorum’ University of Bologna, Bologna, Italy;
,
Enrico BarchiInfectious Diseases Unit, S. Maria Nuova Hospital, Reggio Emilia, Italy;
,
Massimiliano LanzafameInfectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy;
,
Stefano Nicole’Infectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy;
,
Anna Maria Degli AntoniInfectious Diseases and Hepatology Unit, Maggiore University Hospital, Parma, Italy;
,
Isabella BonUnit of Microbiology, ‘Alma Mater Studiorum’ University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Maria Carla ReUnit of Microbiology, ‘Alma Mater Studiorum’ University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
&
Pierluigi VialeS. Orsola-Malpighi Hospital, Clinic of Infectious Diseases, ‘Alma Mater Studiorum’ University of Bologna, Bologna, Italy;
show all
Pages 352-360 | Received 20 Oct 2017, Accepted 16 Nov 2017, Published online: 06 Dec 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Pilar Vizcarra, José L. Blanco, Rocío Montejano, Eugenia Negredo, Nuria Espinosa & José L. Casado. (2020) Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy. Infectious Diseases 52:3, pages 202-206.
Read now
María Fontecha, Marta Monsalvo, Miguel A. Rodriguez-Sagrado, María J. Vivancos, Ana Moreno & José L. Casado. (2019) Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir. Infectious Diseases 51:4, pages 293-298.
Read now
D. F. Bavaro, D. Di Carlo, P. Zuccalà, F. Bai, F. Incardona, A. Battisti, S. Giachè, E. Salomoni, R. Gagliardini, S. Di Giambenedetto, M. Pecorari, M. Zazzi, A. De Luca, A. Bezenchek & S. Lo Caputo. (2019) Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort. Infectious Diseases 51:3, pages 234-239.
Read now

Articles from other publishers (9)

Elaine Monteiro Matsuda, Ivana Barros Campos, Isabela Penteriche de Oliveira, Daniela Rodrigues Colpas, Giselle Ibete Silva López-Lopes, Victor Oliveira Chiavegato & Luís Fernando de Macedo Brígido. (2023) Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction. The Brazilian Journal of Infectious Diseases 27:3, pages 102757.
Crossref
Laura Magnasco, Rachele PincinoGiuseppe PasculliYagai BoubaFrancesco SaladiniDavide Fiore BavaroAndrea De VitoRossana LattanzioRomina CorsiniMaurizio ZazziFrancesca IncardonaBarbara RossettiAntonia Bezenchek, Vanni BorghiAntonio Di Biagio. (2022) Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen. AIDS Research and Human Retroviruses 38:6, pages 463-471.
Crossref
Constance Delaugerre, Marie-Laure Nere, Sabrina Eymard-Duvernay, Alix Armero, Laura Ciaffi, Sinata Koulla-Shiro, Adrien Sawadogo, Ndaye Fatou Ngom Gueye, Cheik Tidiane Ndour, Mireille Mpoudi Ngolle, Ali Amara, Marie-Laure Chaix & Jacques Reynes. (2021) Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial). Journal of Antimicrobial Chemotherapy 76:5, pages 1286-1293.
Crossref
Peng-Le Guo, Hao-Lan He, Xie-Jie Chen, Jin-Feng Chen, Xiao-Ting Chen, Yun Lan, Jian Wang, Pei-Shan Du, Huo-Lin Zhong, Hong Li, Cong Liu, Li-Ya Li, Feng-Yu Hu, Xiao-Ping Tang, Wei-Ping Cai & Ling-Hua Li. (2021) Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China. Frontiers in Pharmacology 11.
Crossref
Leonardo Calza, Vincenzo Colangeli, Marco Borderi, Diletta Testi, Bianca Granozzi, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2020) Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy. Journal of Antimicrobial Chemotherapy 75:11, pages 3327-3333.
Crossref
Marc-Antoine Valantin, Lise Durand, Marc Wirden, Lambert Assoumou, Fabienne Caby, Cathia Soulié, Thi Thu-Thuy Nguyen, Roland Tubiana, Myriam Kirstetter, Helga Junot, Anne-Geneviève Marcelin, Gilles Peytavin, Patrick Tilleul & Christine Katlama. (2019) Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study. Journal of Antimicrobial Chemotherapy 74:9, pages 2716-2722.
Crossref
Jim Young, Alexandra U Scherrer, Alexandra Calmy, Philip E Tarr, Enos Bernasconi, Matthias Cavassini, Anna Hachfeld, Pietro Vernazza, Huldrych F Günthard & Heiner C Bucher. (2018) The Comparative Effectiveness of NRTI-Sparing Dual Regimens in Emulated Trials using Observational Data from the Swiss HIV Cohort Study. Antiviral Therapy 24:5, pages 343-353.
Crossref
Gabriele Arendt, Svenja Schlonies, Eser Orhan & Olaf Stüve. (2019) Simplification of combination antiretroviral therapy (cART) and the brain—a real-life experience. Journal of NeuroVirology 25:2, pages 174-182.
Crossref
Daniel Chastain, Melissa Badowski, Emily Huesgen, Neha Sheth Pandit, Andrea Pallotta & Sarah Michienzi. (2019) Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. Journal of the International Association of Providers of AIDS Care (JIAPAC) 18, pages 232595821986732.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.